Dangerous Drugs
A personal injury lawyer from VanDerGinst Law, P.C. knows what encompasses drug litigation, drug lawsuits, drug side effects or any and all things pertaining to drugs injuring those who use them for medical treatment. While drugs are often tested ad nauseum to ensure they are safe for consumption by the public, dangerous drugs sometimes make their way to the public market. When a drug you use or haved used in the past is placed under a drug recall or a is suspended from sale pending further investigation, your first call should be to an educated and experienced drug lawyer.
Side effects are common knowledge in regards to modern drugs. So long as the health of the patient is advanced further by the use of the drug than it is adversely affected by its side effects, a drug will remain in use and on the free market. However, despite rigorous testing and regulation, drugs sometimes cause dangerous side effects after their introduction to market and patients can be left unaware of potential dangers.
When a drug causes dangerous side effects, including illness and death, the drug company responsible for the drug's manufacture is liable for any damages caused to patients who suffered from any undocumented risk of harm stemming from the drug treatment. In addition, medical professionals who prescribed the drug may also share liability under certain circumstances.
Mass torts is the term used to refer to pending litigation against the manufacturer of a dangerous drug. The Food and Drug Administration (FDA) regulates the pharmaceutical industry and issues numerous warnings and recalls regarding the safety of drugs every year. Despite the FDA's efforts to protect the consumer, dangerous drugs are still on the market and can result in serious injury or death of the patient. Mass torts are meant to provide people injured by dangerous drugs the ability to seek compensation through the legal system.
By law, drug manufacturers are responsible for injuries incurred by the patient if the product they sell is defective or unreasonably dangerous. A mass tort law firm is dedicated to serving the people who have been injured by dangerous drugs by holding drug manufacturers accountable for their products. Unfortunately, some drugs are still marketed by drug companies even after evidence of serious side effects or death had been noted.
The sale and marketing of dangerous drugs can happen in several ways. For example, the consumer may not be warned of potential serious side effects, the manufacturing process may be flawed, or the product itself may be defective. In all these cases, the manufacturer is liable and can be sued for damages even if they were unaware of the danger. It does not matter how carefully the product was produced or labeled.
Our comprehensive library of drug information serves as a resource to patients across the country who may have suffered as the result of dangerous drug side effects.
If you or a loved one has suffered an injury, illness or death after exposure to a dangerous pharmaceutical, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Dangerous Drugs
More Information
| Related Links
|
Links on the Web
 Food and Drug Administration--RecallsRecall information from FDA |
| Tue, 06 May 2008 23:30:00 GMT Blount Fine Foods Issues Allergy Alert On Undeclared Shrimp in All Natural New England Clam Chowder, 20 Oz Cup (May 6) Blount Fine Foods is recalling Blount All Natural New England Clam Chowder, Net Wt. 20 oz with Lot: 0424086D, Sell by date: 6/23/2008, because it may contain undeclared shrimp. People who have an allergy or severe sensitivity to shrimp run the risk of serious or life-threatening allergic reaction if they consume these products. The firm has recovered 1,400 of 1,416 units produced, 16 units are in distribution. Click here to read this Dangerous Drugs news article. |
| Tue, 06 May 2008 17:25:00 GMT Updated Press Release: Lezza Blue Raspberry Italian Ice Recalled The product is in round plastic pint containers with a lot code of 2116. Blue Raspberry is the flavor of the product. The product was distributed to retail outlets in Illinois, Wisconsin, Oklahoma, Texas, Michigan, Louisiana, Kansas, Indiana, Georgia, Florida, Ohio, Missouri, Kentucky, Nebraska, Pennsylvania, Arkansas, and Minnesota during 2006 and 2007. Click here to read this Dangerous Drugs news article. |
| Tue, 06 May 2008 11:25:00 GMT Hydrox Labs Issued a Voluntary Recall of Alcohol-Free Mouthwash Nationwide Distributed by Cardinal Health (May 2) Hydrox Labs has issued a voluntary recall of Cardinal Health labeled alcohol-free mouthwash. The mouthwash has been tested and been found positive for Burkholderia cepacia (B. cepacia). The CDC has confirmed hospital illnesses in one state associated with the use of the affected mouthwash. Click here to read this Dangerous Drugs news article. |
| Fri, 02 May 2008 21:33:00 GMT Little Bay Baking Company Issues Nationwide Allergy Alert On Undeclared Soy In Corn Bread And Muffin Mix in 12.6 Ounce White Paper Tin Tie Bag Package (May 2) Little Bay Baking Company of Newmarket, New Hampshire is recalling all bags of CORN BREAD AND MUFFIN MIX sold before May 2, 2008 because it contains undeclared soy. People who have an allergy or severe sensitivity to soy run the risk of serious or life-threatening allergic reaction if they consume these products. Click here to read this Dangerous Drugs news article. |
| Mon, 28 Apr 2008 14:50:00 GMT Lifetime Brands Voluntarily Recalls Certain Items Nationwide from its Pfaltzgraff Villa della Luna pattern and Nautica J Class pattern (Red Only) Stoneware Dinnerware Product Lines (April 28) Lifetime Brands, Inc., of Garden City, New York, today announced that, as a result of its internal compliance and independent product testing programs, it recently became aware that certain Pfaltzgraff Villa della Luna pattern and Nautica J Class pattern stoneware dinnerware products may exceed the Food and Drug Administration's guidance levels for lead and/or cadmium. Click here to read this Dangerous Drugs news article. |
| Mon, 28 Apr 2008 14:50:00 GMT Actavis Totowa (formerly known as Amide Pharmaceutical, Inc.) recalls all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP) as precaution (April 25) Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. The voluntary all lot recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate. Click here to read this Dangerous Drugs news article. |
| Medical Devices News From Medical News Today Latest Medical Devices News From Medical News Today. |
| Fri, 09 May 2008 04:00:00 PDT Radiotherapy Delivery Up To Eight Times Faster, Accuracy Improved With Less Time For Movement The University of Alabama at Birmingham (UAB) this month became the first U.S. medical center to offer a speedier cancer radiation therapy. The new technique can turn a 20-minute radiotherapy session into a 90-second session for selected patients. Additionally, the new therapy saves healthy human tissue from unwanted radiation exposure at rates that are the same or better than other radiotherapy techniques, according to doctors at the UAB Comprehensive Cancer Center. Click here to read this Dangerous Drugs news article. |
| Fri, 09 May 2008 04:00:00 PDT Brain Imaging Improves Anxiety Treatment Wouldn't it be nice if our doctors could predict accurately whether we would respond to a particular medication? This question is important because research studies provide information about how groups of patients tend to respond to treatments, but inevitably, differences among groups of patients with the same diagnosis mean that findings about groups of patients may not apply to individuals from those groups. Click here to read this Dangerous Drugs news article. |
| Fri, 09 May 2008 03:00:00 PDT New Category Of Device For Stone Extraction To Help Render Patients Free From Kidney Stones And Stones In The Urinary Tract The NGage Nitinol Stone Extractor, engineered and manufactured by Cook Medical, represents an entirely new category in the evolution of stone extraction. Utilising Cook's revolutionary nitinol technology, the NGage allows physicians to easily engage, release and extract stones even in the most difficult anatomy while providing improved irrigation, visibility and enhanced efficiency. Click here to read this Dangerous Drugs news article. |
| Fri, 09 May 2008 02:00:00 PDT Magnet Lab Researchers Make Observing Cell Functions Easier Now that the genome (DNA) of humans and many other organisms have been sequenced, biologists are turning their attention to discovering how the many thousands of structural and control genes -- the "worker bees" of living cells that can turn genes on and off -- function.To do that, they need to develop new techniques and tools. Click here to read this Dangerous Drugs news article. |
| Fri, 09 May 2008 02:00:00 PDT Magnetic Resonance Imaging Warms Up Standard magnetic resonance imaging, MRI, is a superb diagnostic tool but one that suffers from low sensitivity, requiring patients to remain motionless for long periods of time inside noisy, claustrophobic machines. Click here to read this Dangerous Drugs news article. |
| Fri, 09 May 2008 02:00:00 PDT CardioTech Receives Approval For A Second Graft Size For CardioPass Clinical Trial CardioTech International, Inc. (AMEX: CTE), a developer and manufacturer of advanced medical devices and materials for the treatment of a broad range of disease states, announced that it has received the necessary Ministry of Health approval to add a 4mm graft for the clinical trial of CardioPass? , the Company's proprietary synthetic coronary bypass graft. Until now, the trial was only approved for a 5mm graft. Click here to read this Dangerous Drugs news article. |
